Results 191 to 200 of about 4,398,820 (307)

Chiral separation of chloroalkanes with the chromatographic column onboard Martian rovers

FEBS Letters, EarlyView.
Computer image of the Rosalind Franklin Rover of ESA's ExoMars mission. ExoMars is scheduled to land on planet Mars in Oxia Planum in 2029. This area represents an interesting spot to look for biosignatures. Investigations of ExoMars include measurement on molecular chirality. We show that chiral chloroalkanes, that have been identified on Mars, can be
Asma Merzougui, Agnes Banreti, Armelle L. Ernst, Guillaume Leseigneur, Uwe J. Meierhenrich   +4 more
wiley   +1 more source

Acknowledgement to reviewers

Reading & Writing, 2019
Editorial Office
doaj   +1 more source

Neoadjuvant chemotherapy in women with triple-negative breast cancer: real world results from Western Kenya. [PDF]

Oncologist
Rangoonwala HI, Busakhala N, Kiprono H, Sitienei L, Chesori E, Niemeyer K, Sabul W, Opakas J, Ngelel A, Pabon-Rodriguez F, Keitany K, Melly E, Hunter-Squires J, Miller KD, Kisilu N, Loehrer PJ, Morgan JS.   +16 more
europepmc   +1 more source

Prospecting the protein design landscape

FEBS Letters, EarlyView.
This review outlines the current state of various protein design approaches. We discuss the current possibilities enabled by recently released tools, highlight future avenues to pursue in protein design, and underscore the crucial role of key databases and resources for successful protein design workflows.
Jakob R. Riccabona, Katharina T. Stonig, Jens Meiler, Clara T. Schoeder, Monica L. Fernández‐Quintero   +4 more
wiley   +1 more source

From benchmarking to global leadership: Singapore's health sciences authority's journey to WHO maturity level 4 and WHO-Listed Authority status for medicines. [PDF]

Front Med (Lausanne)
Toh D, Lim A, Chan A, Chia A, Ang PS, Tan A, Foo B, Chan B, Chong L, Choo Q, Choong CT, Ho C, Chua SW, Chuah SC, Rodrigues CL, Chuah D, Sun D, Koh D, Yeo D, Tan E, Goh E, Lee E, Ee F, Foo F, Ge XW, Goh CH, Han PY, Poh J, Low J, Teo J, Ng J, Lai WF, Lee HK, Lim BK, Lim LL, Lim N, Lin S, Ling BL, Tan L, Looi YH, Low MY, Limenta M, Ng LT, Ong SY, Peck LF, Soh S, Seng TJ, Shinta, Sachidanandan S, Soh XW, Tan SK, Tang X, Tham MY, Toh T, Gan V, Lai V, Xu Y, Yang S, Yeo W, Yip YY, Chan CL.   +60 more
europepmc   +1 more source

L‐aspartate oxidase provides new insights into fumarate reduction in anaerobic darkness in Synechocystis sp. PCC6803

FEBS Letters, EarlyView.
Synechocystis strains deficient in succinate dehydrogenase (SDH) secrete more succinate than the WT under dark anaerobic conditions, supporting that SDH then primarily acts as SDH, not as a fumarate reductase. L‐aspartate oxidase (Laspo) from Synechocystis is functional under anaerobic conditions, reducing fumarate to succinate.
Kateryna Kukil, Jeffrey A. Hawkes, Cecilia Blikstad, Pia Lindberg   +3 more
wiley   +1 more source

Clinical phenotypes, endotypes, and biomarker profiles of immediate rituximab hypersensitivity reactions: a prospective pharmacovigilance study. [PDF]

Front Allergy
Yotinnoratham N, Laisuan W, Chanprapaph K, Kanokrungsee S, Setthaudom C, Onpun S, Mongkolpathumrat P, Buranapraditkun S, Chungcharoenpanich A, Dechapaphapitak N, Oncham S, Tongdee N, Khamkaew S, Lertnawapan R, Klaewsongkram J.   +14 more
europepmc   +1 more source

Artificial molecular machines and motors—Design and control of nanoscale motion

FEBS Letters, EarlyView.
Molecules are constantly moving because of thermal fluctuations, but random motion alone cannot be exploited to perform directional tasks. Artificial molecular machines use chemical, electrical, or light energy to bias this motion. Molecular shuttles, rotary motors, and supramolecular pumps illustrate how nanoscale movement can be controlled and ...
Leonardo Andreoni, Alberto Credi
wiley   +1 more source

Leucine‐rich glioma inactivated 1 (LGI1) is a ganglioside‐binding protein

FEBS Letters, EarlyView.
Neuronal hyperexcitability associated with a decrease/absence of the extracellular protein LGI1 has been suggested to be primarily due to the downregulation of Kv1 channel expression. The molecular mechanisms underlying this decrease have not yet been elucidated.
Kévin Debreux, Christian Lévêque, Fodil Azzaz, Marion Sangiardi, Sarosh R Irani, Michael Seagar, Jacques Fantini, Oussama El Far   +7 more
wiley   +1 more source

Apixaban Use Before Kidney Transplantation: Is Reversal Necessary? [PDF]

Pharmacotherapy
Cotiguala L, Przybylski A, Linberger L, Brokhof M, Kenyon N, Joyce C, Dierker M, Ferguson K, Rech MA, Trotter C, Aguirre O, Lopez-Soler RI.   +11 more
europepmc   +1 more source